TERBIVICE 250 TERBINAFINE 250mg. IP

Terbivice 250 tablets contain terbinafine 250 mg and are used to treat fungal infection of the toenail or fingernail caused by dermatophytes. Main uses: treatment of onychomycosis of the toenail caused by dermatophytes (tinea unguium); treatment of onychomycosis of the fingernail caused by dermatophytes (tinea unguium); diagnosis of the nail infection should be confirmed by laboratory testing (KOH preparation, fungal culture or nail biopsy) before treatment is started.

Common side effects of Terbivice 250 Tablet include headache; diarrhoea; skin rash; indigestion (dyspepsia); raised liver enzymes on blood tests; itching (pruritus). Get medical help at once if you notice liver injury, including liver failure that has required liver transplant or been fatal; severe skin reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme; severe neutropenia (very low white blood cell count).

Each Terbivice 250 tablet contains Terbinafine 250 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Terbivice 250 Tablet only as your doctor advises.

The MRP of Terbivice 250 Tablet is ₹145.31 for a pack of 10x1x7 (Blister). For chemists and distributors, the PTR is ₹110.71 and the PTS is ₹99.64.

Each Terbivice 250 tablet contains Terbinafine 250 mg. It comes in a pack of 10x1x7 (Blister).

Terbinafine in the tablet is an allylamine antifungal. It works against the dermatophyte fungi that take hold in the nail plate and cause the infection there. By acting on the fungus at the site of infection in the nail, the tablet supports clearing of the infection over the treatment period.

Must not be used by patients with a history of allergic reaction to oral terbinafine, because of the risk of anaphylaxis. Must not be used by patients with chronic or active liver disease. Check with a doctor first if there is any liver problem; liver function tests should be done before treatment and during treatment, and terbinafine should be discontinued if liver injury develops. Check with a doctor first if taste or smell changes, depressive symptoms, skin rash or unexplained fever occur during treatment; taste or smell disturbance may be prolonged or permanent, and terbinafine should be discontinued if it occurs. Check with a doctor first if the blood count shows a low neutrophil count; if the neutrophil count is 1000 cells/mm³ or less, terbinafine should be discontinued.

Terbivice 250 Tablet is a brand of Vibcare Pharma, sold through its Grace division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.